¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary site"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary aqueous
    Àç»ý¹æ¼ö, ÀÌÂ÷¹æ¼ö
  • secondary attack rate
    ÀÌÂ÷¹ßº´·ü
  • secondary biliary cirrhosis
    ¼Ó¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • secondary cardiomyopathy
    ÀÌÂ÷½ÉÀå±ÙÀ°º´(Áõ), ÀÌÂ÷½É±Ùº´(Áõ)
  • secondary constriction
    ÀÌÂ÷ÇùÂø
  • secondary culture
    ÀÌÂ÷¹è¾ç
  • secondary dentin
    ÀÌÂ÷»ó¾ÆÁú
  • secondary dentition
    ÀÌÂ÷Ä¡¾Æ
  • secondary disease
    ¼Ó¹ßº´, ¼Ó¹ßÁúȯ
  • secondary dysmenorrhea
    ¼Ó¹ß¿ù°æÅë
  • secondary ending
    ÀÌÂ÷Á¾¸»
  • secondary evoked response
    ÀÌÂ÷À¯¹ß¹ÝÀÀ
  • secondary gout
    ÀÌÂ÷Åëdz
  • secondary hemorrhage
    ¼Ó¹ßÃâÇ÷, ÀÌÂ÷ÃâÇ÷
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • site
    ºÎÀ§
  • telomeric site
    ¸»´ÜºÎÀ§
  • web site
    À¥½ÎÀÌÆ®
  • secondary amenorrhea
    ÀÌÂ÷¹«¿ù°æ, ¼Ó¹ß¹«¿ù°æ
  • secondary aqueous
    Àç»ý¹æ¼ö, ÀÌÂ÷¹æ¼ö
  • secondary cardiomyopathy
    ÀÌÂ÷½ÉÀå±ÙÀ°º´Áõ
  • secondary constriction
    ÀÌÂ÷ÇùÂø
  • secondary contact
    ÀÌÂ÷Á¢ÃË
  • secondary culture
    µÎ¹øÂ°½É±â
  • secondary biliary cirrhosis
    ¼Ó¹ß¾µ°³°ü°£°æÈ­(Áõ)
  • secondary dentition
    (¢¡permanent tooth) °£´Ï, ¿µ±¸Ä¡¾Æ
  • secondary disease
    ¼Ó¹ßº´
  • secondary dysmenorrhea
    ÀÌÂ÷¿ù°æÅë
  • secondary ending
    ÀÌÂ÷Á¾¸»
  • secondary gout
    ÀÌÂ÷Åëdz
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • privileged site
    Ưº°°Ý¸®ºÎÀ§
  • receptor site
    ¼ö¿ëüºÎÀ§.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • definitive site
    Âø»óÀÚ¸®
  • donor site
    ±Þ¿©ºÎ.
  • fundic site
    ÀڱùٴÚÀÓ½Å
  • internal ribosomal entry site (IRES)
    ³»ºÎ ¸®º¸¼Ø °áÇÕºÎÀ§
  • mutational site
    (µ¹¿¬)º¯ÀÌÁ¡.
  • packaging site
    ²Ù¸®±âºÎÀ§
  • placental site trophoblastic tumor
    ŹݺÎÂøºÎÀ§ À¶¸ð»óÇǼºÁ¾¾ç
  • privileged site
    Ưº°°Ý¸®ºÎÀ§
  • receptor site
    ¼ö¿ëüºÎÀ§.
  • variations of site
    À§Ä¡º¯ÀÌ
  • web site
    À¥ ½ÎÀÌÆ®
  • culture, secondary
    ÀÌÂ÷¹è¾ç
  • haploid secondary gametocyte
    Ȭ¹è¼öüÀÌÂ÷»ý½Ä¼¼Æ÷
  • immune response, secondary
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
  • immunodeficiency syndrome, secondary
    ÀÌÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¼Ó¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Secondary visceral nucleus
    ÀÌÂ÷³»Àå½Å°æÇÙ
    [¿¾ ¿ë¾î] Á¦2Àå½Å°æÇÙ
  • Secondary abdominal implantation
    ÀÌÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÌÂ÷Àûº¹ºÎÂø»ó
  • Secondary bone
    ÀÌÂ÷»À
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ
  • Secondary osteon
    ÀÌÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¿ø
  • Secondary osteogenic bud
    ÀÌÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÇü¼º¾Æ
  • Secondary ossification center
    ÀÌÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary ossification center [Epiphyseal ossification cente
    ÀÌÂ÷»À¹ß»ýÁ᫐ [»À³¡»À¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary bone trabecula
    ÀÌÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¼ÒÁÖ
  • Secondary dentin
    ÀÌÂ÷»ó¾ÆÁú
    [¿¾ ¿ë¾î] ÀÌÂ÷»ó¾ÆÁú
  • Secondary nodule
    ÀÌÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÌÂ÷¼ÒÀý
  • Secondary villus
    ÀÌÂ÷À¶¸ð
    [¿¾ ¿ë¾î] ÀÌÂ÷À¶¸ð
  • Secondary pregnancy
    ÀÌÂ÷ÀÓ½Å
    [¿¾ ¿ë¾î] ÀÌÂ÷ÀÓ½Å
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷Á¤¸ð¼¼Æ÷
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] Á¦ÀÌÁ¤¸ð¼¼Æ÷
  • Secondary nasal septum
    ÀÌÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÌÂ÷ºñÁß°Ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary isotope effect
    ÀÌÂ÷ µ¿À§¿ø¼ÒÈ¿°ú(ì£ó­ÔÒêÈêªáÈüùÍý)
  • secondary lysosome
    ÀÌÂ÷(ì£ó­) ¶óÀ̼ҼØ
  • secondary malnutrition
    ÀÌÂ÷ ¿µ¾ç½ÇÁ¶(ì£ó­ç½å×ã÷ðà)
  • secondary messenger
    ÀÌÂ÷ Àü·É (ì£ó­îîÖµ)
  • secondary metabolite
    ÀÌÂ÷ ´ë»ç¹°(ì£ó­ÓÛÞóÚª)
  • secondary plant constituent
    ÀÌÂ÷ ½Ä¹°¼ººÐ(ì£ó­ãÕÚªà÷ÝÂ)
  • secondary plot
    ÀÌÂ÷(ì£ó­) Ç÷Ô
  • secondary protein derivative
    ÀÌÂ÷ ´Ü¹éÁúÀ¯µµÃ¼(ì£ó­Ó±ÛÜòõë¯Óôô÷)
  • secondary solvent
    ÀÌÂ÷ ¿ë¸Å(ì£ó­éÁØÚ)
  • secondary standard
    ÀÌÂ÷ Ç¥ÁØ(ì£ó­øöñÞ)
  • secondary structure
    ÀÌÂ÷ ±¸Á¶(ì£ó­Ï°ðã)
  • super-secondary structure
    ÃÊÀÌÂ÷ ±¸Á¶(õ±ì£ó­Ï°ðã)
  • acceptor site
    ¼ö¿ëºÎÀ§ (â¥é»Ý»êÈ)
  • active site
    Ȱ¼º(üÀàõ)ÀÚ¸®
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
E* lesion on the erythrocyte cell membrane at the site of complement fixation
FMR fragile site mental retardation [syndrome]; Friend-Moloney-Rauscher [antigen]
fra fragil [site]
FRAXE X-linked mental retardation-fragile site [syndrome]
HBVS hepatitis B virus integration site
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SP Secondary Polycythaemia
SIMS Secondary ion mass spectroscopy
SP Secondary progressive
ToF-SIMS Time of Flight Secondary Ion Mass Spectrometry
SE secondary electron
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • brain vesicle`s secondary
    ÀÌÂ÷ ³úÆ÷
    Èı⠹èÅ ºÐÈ­·Î Çü¼ºµÇ´Â ³× °³ÀÇ ³ú³¶À¸·Î¼­ Àü³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Á¾³ú¿Í °£³ú, ´É³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Èijú¿Í ¼ö³ú¸¦ Æ÷ÇÔÇÑ´Ù.
  • secondary activation
    ÀÌÂ÷Àû Ȱ¼º
  • secondary amine
    ÀÌÂ÷ ¾Æ¹Î
  • secondary anemia
    ¼Ó¹ß¼º ºóÇ÷
  • secondary bond
    ÀÌÂ÷ °áÇÕ
    ÀϹÝÀûÀ¸·Î ¼ö¼Ò °áÇÕ, ¹Ýµ¥¸£¹ß½º Èû µîÀ» ¸»ÇÏ¸ç °áÇÕ·ÂÀº ÀÏÂ÷ °áÇշ¿¡ ºñÇÏ¸é ¸Å¿ì ÀÛ´Ù
  • secondary caries
    ÀÌÂ÷ ¿ì½Ä
    ½ÉºÎ¿¡ ¹ÌÄ£ ¹ý¶ûÁú ¿ì½ÄÀÌ »ó¾ÆÁú °æ°è¸¦ ¿·À¸·Î ÆÛÁ®¼­ °Å²Ù·Î Ç¥¸éÂÊÀ¸·Î ÁøÇàÇÏ´Â ¿ì½Ä. ¿ì½ÄÀ» ÃæÀüÇÑ ÈÄ ±× º¯¿¬¿¡¼­ ´Ù½Ã ÀϾ´Â ¿ì½Ä.
  • secondary cementum
    ÀÌÂ÷ ¹é¾ÇÁú, Á¦2¹é¾ÇÁú
    ÀÏÂ÷ ¹é¾ÇÁú ÀÌÈÄ¿¡ Çü¼ºµÈ ¸ðµç ÃþÀ» °¡¸®Å°´Â ¿ë¾î. ¼¼Æ÷¼º ȤÀº ºñ¼¼Æ÷¼ºÀÌ´Ù.
  • secondary crown
    ¿Ü°ü
  • secondary dentin formation
    ÀÌÂ÷ »ó¾ÆÁú Çü¼º
    Åë»óÀûÀÎ ±â´ÉÀû ±×¸®°í ¿­ ÀûÀÎ Àڱؿ¡ ´ëÇÑ Á¡Â÷ÀûÀÎ Ãß°¡Àû »ó¾ÆÁú Çü¼ºÀÌ¸ç ¹æ»ç¼± »çÁø »óÀ¸·Î Ä¡°üºÎ »ó¾ÆÁú µÎ²²ÀÇ ±ÕÀÏÇÑ Áõ°¡ ¾ç»óÀ» º¸À̰í ÀÖ´Ù. ´ëºÎºÐÀÇ ¼ºÀο¡´Â ÀÌ·¯ÇÑ °úÁ¤ÀÌ Á¸ÀçÇϸç ÀÌÀÇ Á¤µµ´Â °³Àο¡ µû¶ó ´Ù¾çÇÏ´Ù. 2Â÷ »ó¾ÆÁúÀº Ä¡¾Æ Ç¥¸é¿¡¼­ Ä¡¼ö±îÁö ¿ì½Ä º´º¯ÀÌ ÁøÇàµÇ´Âµ¥ °É¸®´Â ½Ã°£°ú °Å¸®¸¦ Áõ°¡½ÃŰ°Ô µÈ´Ù. ¶ÇÇÑ Ä¡¼ö°¢°ú °°Àº Ç¥ÃþÀÇ Ä¡¼ö Á¶Á÷À» ¸ÍÃâ ÈÄ ¼ö³â À̳»¿¡ 2Â÷ »ó¾ÆÁú·Î ´ëÄ¡½ÃÅ´À¸·Î½á ¼öº¹ ½Ã¼ú ½Ã ±â°èÀûÀÎ Ä¡¼ö ³ëÃâ °¡´É¼ºÀ» °¨¼Ò½ÃŲ´Ù. ÇÑÆí Àڱؿ¡ ´ëÇÑ Ä¡¼öÀÇ ¹Î°¨¼ºÀ» °¨¼Ò½Ã۱⠶§¹®¿¡ Ä¡¼ö °Ë»ç¿Í Ä¡¾Æ ÁúȯÀÇ Áø´Ü ½Ã À̰ÍÀÌ °í·ÁµÇ¾î¾ß ÇÑ´Ù.
  • secondary diagnosis
    ÀÌÂ÷ Áø´Ü
  • secondary disorder
    ÀÌÂ÷ Àå¾Ö
  • secondary efflorescence
    ¼Ó¹ß¼º ¹ßÁø
  • secondary epithelization vestibuloplasty
    ÀÌÂ÷¼º »óÇÇÈ­ ±¸°­ ÀüÁ¤¼ú
  • secondary gain
    ÀÌÂ÷ À̵æ
    °£Á¢ÀûÀÎ À̵æÀ¸·Î¼­ º¸Åë Áúº´À̳ª ¼è¾àÀ¸·ÎºÎÅÍ ¾ò¾îÁø´Ù. À̰ÍÀº Àڽſ¡°Ô ÇØ·Î¿î Àǹ«³ª Ȱµ¿À» ÇÇÇϰí Åë»óÀûÀ¸·Î´Â µµ¿ÍÁÖÁö ¾Ê´Â »ç¶÷À¸·ÎºÎÅÍ ÁöÁö¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÑ´Ù.
  • secondary healing
    ÀÌÂ÷Àû Ä¡À¯, À̱â À¯ÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
restriction enzyme cutting site <molecular biology> A specific nucleotide sequence of DNA at which a particular restriction enzyme cuts the DNA.
Some sites occur frequently in DNA (for example, every several hundred basepairs), others much less frequently (rare-cutter, for example, every 10,000 base pairs).
(10 Mar 1998)
restriction site A sequence in DNA that can be recognised and cut by a specific restriction enzyme.
(12 Dec 1998)
restriction-site polymorphism DNA polymorphism in which the sequence of one form of the polymorphism contains a recognition site for a particular endonuclease, but the sequence of the other form lacks such a site.
(05 Mar 2000)
chi site <molecular biology> Short, active sequences of DNA which strongly encourages crossing over of chromosomes to occur at that site. These sites become chiasmata more often than other sites.
(05 Jan 1998)
ribosome binding site The region of a messenger RNA molecule that binds the ribosome to initiate translation.
(09 Oct 1997)
cleavage site A sequence in DNA that can be recognised and cut by a specific restriction enzyme.
(12 Dec 1998)
combining site <biochemistry, immunology> Any region of a molecule that binds or reacts with a given compound. Especially of the region of immunoglobulin that combines with the determinant of an appropriate antigen.
(09 Jan 1998)
placental site trophoblastic tumour A tumour usually arising in the uterus of parous women during reproductive years. Histologically, the tumour consists of a predominance of intermediate trophoblastic cells with fibrinoid material and vascular invasion.
(05 Mar 2000)
Con A binding site <biochemistry> A common misuse of the term receptor. Con A binds to the mannose residues of many different glycoproteins and glycolipids and the binding is therefore not to a specific site.
It could be argued that the receptor is the Con A and cells have Con A ligands on their surfaces: certainly this would be less confusing.
(05 Jan 1998)
multiple cloning site Region of a phage or plasmid vector that has been engineered to contain a series of restriction sites that are usually unique within the entire vector. This makes it particularly easy to insert or excise (subclone) DNA fragments.
(18 Nov 1997)
mutagenesis, site-directed Mutagenesis where the mutation is caused by in vitro induction directed at a specific site in a DNA molecule. The most common method involves use of a chemically synthesised oligonucleotide mutant which can hybridise with the DNA target molecule. The resulting mismatch-carrying DNA duplex may then be transfected into a bacterial cell line and the mutant strands recovered.
(12 Dec 1998)
polycloning site Region of a phage or plasmid vector that has been engineered to contain a series of restriction sites that are usually unique within the entire vector. This makes it particularly easy to insert or excise (subclone) DNA fragments.
(18 Nov 1997)
cos site <molecular biology> A 12-nucleotide bases-long segment of single stranded DNA that exists at both ends of the bacteriophage lambda's double-stranded genome.
The two cos sites at the ends of the genome are complementary to one another so that the genome can become circular once the virus has infected a host bacterium. The circular genome can then be duplicated continuously until there are many repeats of it strung together, the cos sites show the virus where to cut them apart right before they are packaged into individual capsids as new progeny viruses ready to infect more host cells.
(10 Nov 1998)
privileged site An anatomic area lacking lymphatic drainage, such as the brain, cornea, and hamster cheek pouch, in which heterologous tumours may grow because the host does not become sensitised.
(05 Mar 2000)
P site <molecular biology> The peptidyl tRNA binding site on the ribosome, the one to which the growing chain is attached, the incoming aminoacyl tRNA attaches to the A site.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary industry
    Á¦ 2Â÷ »ê¾÷
  • secondary school
    Áßµî Çб³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á